EMQN integrates Trinean’s DropSense™ into its standards QC procedures and quality assessment schemes for Molecular Genetic Labs

Manchester, UK and Gentbrugge, Belgium: 16 February 2016 - EMQN, Europe's leading organization for quality promotion and assessment in Clinical Genetic Testing, and Trinean, provider of microfluidic spectrophotometry platforms, today announced that the DropSenseTM96 has been integrated by EMQN as the standard QC tool for DNA samples used in its External Quality Assessment (EQA) schemes.

EMQN's EQA schemes are designed to test the whole analytical process of a clinical laboratory; the ability to interpret data in the light of clinical information supplied with a referral, and to produce a clear and accurate report. The EQA process, which allows diagnostic labs to benchmark and improve their laboratory performance, requires high quality materials and EMQN has adopted the Trinean DropSenseTM96 reader with its innovative purity analysis cDropTM software for the QC of all DNA material used.

 More info on the press release or on Trinean's website.

Next > Green Biologics partners with Acme Hardesty

Previous > Mainstay Medical full year 2015 preliminary results and business update